+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Daiichi Sankyo Co Ltd - logo

Daiichi Sankyo is a global pharmaceutical company and one of the largest pharmaceutical company in Japan. The company offers therapies in the areas of hypertension, dyslipidemia, diabetes, acute coronary syndrome, metastatic melanoma, cardiology, oncology, pain, and others. Formerly known as Sankyo Pharma, it changed its name to Daiichi Sankyo in April 2006. The company was founded in 1996 and is based in Parsippany, New Jersey.

Murine Double Minute 2 (MDM2) Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Murine Double Minute 2 (MDM2) Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Enhancer of zeste homolog 2 (EZH2) Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Enhancer of zeste homolog 2 (EZH2) Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Asia Pacific Alzheimer's Diagnosis and Treatment Market Outlook to 2035 - Product Thumbnail Image

Asia Pacific Alzheimer's Diagnosis and Treatment Market Outlook to 2035

  • Report
  • February 2023
  • 243 Pages
  • Asia Pacific
From
From
From
From
From
From
Leukemia Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Leukemia Therapeutics - Global Strategic Business Report

  • Report
  • November 2024
  • 193 Pages
  • Global
From
From
From
Genitourinary Drugs - Global Strategic Business Report - Product Thumbnail Image

Genitourinary Drugs - Global Strategic Business Report

  • Report
  • November 2024
  • 194 Pages
  • Global
From
Loading Indicator